- Shopping Bag ( 0 items )
Doody's Review ServiceReviewer: Willem J de Villiers, MD, PhD, MHCM (University of Kentucky College of Medicine)
Description: Inflammatory bowel disease (IBD) is an increasingly important health problem, and novel diagnostic and therapeutic approaches are rapidly evolving. IBD is also an important example of a complex chronic inflammatory disease where genetics, environmental risk factors, and mucosal immune dysregulation interact to establish different phenotypic patterns of disease. This yearbook is the first in an annual series and provides clinicians and scientists with state-of-the-art updates on several hot topics in IBD clinical practice and research.
Purpose: The book provides an update of the latest information in IBD clinical practice and research. This a rapidly evolving field and an annual update is required. An international panel of experts have reviewed the latest developments in IBD and the objectives are well met.
Audience: The book is predominantly targeted at gastroenterologists (both adult and pediatric), especially those with a special interest in inflammatory bowel disease. The international panel of experts are credible authorities in their respective fields.
Features: The book covers new developments in IBD clinical practice and research, including conventional therapy, biological therapies, the role of serodiagnostics, exciting novel findings in genetics and IBD, description of new imaging trends in IBD as well as the rationale for probiotic therapy in IBD management. I particularly liked the chapters on genetics and serodiagnostics in IBD. The tables and images were very informative and concise and the references are up to date.
Assessment: This is an excellent addition to the Yearbook series. The chapters are well chosen and provide evidence-based data on new therapies. The succinct chapters allow easy reference in a clinical setting.